Shanghai Junshi Biosciences Co., Ltd. (01877) at a glance
Code
01877
Company
Shanghai Junshi Biosciences Co., Ltd.
Local name
JUNSHI BIO
Market
Hong Kong Stock Exchange
Share price
HK$15.67 -0.27 (-1.69%)Nov 11 close
Prices are from Yahoo! Finance and may be delayed. Always check the latest price before trading.
Shanghai Junshi Biosciences Co., Ltd. (01877) Stock Price History
Shanghai Junshi Biosciences Co., Ltd. closed at HK$15.67 on Nov 11, 2026, −11.2% over 1 month, −37.5% over 1 year.
Price5-day MA25-day MAHang Seng IndexDisclosures
1-Month HighHK$17.34Oct 12
1-Month LowHK$15.02Nov 3
1-Week Change−0.1%vs Nov 4
1-Month Change−11.2%vs Oct 9
If you had invested HK$10,000 1 month ago, it would be worth HK$9,037 today (−9.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +0.2%, while this stock moved −9.6%.
Last 10 Trading Days
Date
Close
Change
% Change
Nov 11 (Wed)
HK$15.67
−0.27
−1.69%
Nov 10 (Tue)
HK$15.94
+0.22
+1.40%
Nov 9 (Mon)
HK$15.72
+0.03
+0.19%
Nov 6 (Fri)
HK$15.69
−0.24
−1.51%
Nov 5 (Thu)
HK$15.93
+0.24
+1.53%
Nov 4 (Wed)
HK$15.69
+0.67
+4.46%
Nov 3 (Tue)
HK$15.02
−0.37
−2.40%
Nov 2 (Mon)
HK$15.39
+0.13
+0.85%
Oct 30 (Fri)
HK$15.26
−0.62
−3.90%
Oct 29 (Thu)
HK$15.88
−0.18
−1.12%
Price5-day MA25-day MAHang Seng IndexDisclosures
3-Month HighHK$20.22Aug 13
3-Month LowHK$15.02Nov 3
1-Month Change−11.2%vs Oct 9
3-Month Change−20.7%vs Aug 11
If you had invested HK$10,000 3 months ago, it would be worth HK$7,926 today (−20.7%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −5.2%, while this stock moved −20.7%.
Last 10 Trading Days
Date
Close
Change
% Change
Nov 11 (Wed)
HK$15.67
−0.27
−1.69%
Nov 10 (Tue)
HK$15.94
+0.22
+1.40%
Nov 9 (Mon)
HK$15.72
+0.03
+0.19%
Nov 6 (Fri)
HK$15.69
−0.24
−1.51%
Nov 5 (Thu)
HK$15.93
+0.24
+1.53%
Nov 4 (Wed)
HK$15.69
+0.67
+4.46%
Nov 3 (Tue)
HK$15.02
−0.37
−2.40%
Nov 2 (Mon)
HK$15.39
+0.13
+0.85%
Oct 30 (Fri)
HK$15.26
−0.62
−3.90%
Oct 29 (Thu)
HK$15.88
−0.18
−1.12%
Price25-day MA75-day MAHang Seng IndexDisclosures
6-Month HighHK$26.10May 11
6-Month LowHK$15.02Nov 3
3-Month Change−20.7%vs Aug 11
6-Month Change−40.0%vs May 11
If you had invested HK$10,000 6 months ago, it would be worth HK$6,004 today (−40.0%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −7.9%, while this stock moved −40.0%.
Monthly Closes
Month
Month-End Close
Monthly %
Nov 2026
HK$15.67
+2.7%
Oct 2026
HK$15.26
−20.9%
Sep 2026
HK$19.30
+8.7%
Aug 2026
HK$17.75
−2.8%
Jul 2026
HK$18.26
+9.7%
Jun 2026
HK$16.65
−20.9%
May 2026
HK$21.06
−20.0%
Price25-day MA75-day MAHang Seng IndexDisclosures
52-Week HighHK$28.96Apr 17
52-Week LowHK$15.02Nov 3
Year to Date−26.6%vs Dec 31
From 52-Week High−45.9%Apr 17
If you had invested HK$10,000 1 year ago, it would be worth HK$6,253 today (−37.5%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −8.9%, while this stock moved −37.5%.
Monthly Closes
Month
Month-End Close
Monthly %
Nov 2026
HK$15.67
+2.7%
Oct 2026
HK$15.26
−20.9%
Sep 2026
HK$19.30
+8.7%
Aug 2026
HK$17.75
−2.8%
Jul 2026
HK$18.26
+9.7%
Jun 2026
HK$16.65
−20.9%
May 2026
HK$21.06
−20.0%
Apr 2026
HK$26.32
+13.6%
Mar 2026
HK$23.16
+13.1%
Feb 2026
HK$20.48
−4.2%
Jan 2026
HK$21.38
+0.2%
Dec 2025
HK$21.34
−15.7%
Nov 2025
HK$25.32
−4.7%
Price13-week MA26-week MAHang Seng Index
3-Year HighHK$34.50Sep 1, 2025
3-Year LowHK$9.24Apr 15, 2024
Annualized Return−10.2%
Max Drawdown−61.0%
If you had invested HK$10,000 3 years ago, it would be worth HK$7,238 today (−27.6%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved +39.3%, while this stock moved −27.6%.
Yearly Closes
Year
Year-End Close
Yearly %
2026 (YTD)
HK$15.67
−26.6%
2025
HK$21.34
―
Price13-week MA26-week MAHang Seng Index
5-Year HighHK$63.50May 9, 2022
5-Year LowHK$9.24Apr 15, 2024
Annualized Return−19.3%
Max Drawdown−85.4%
If you had invested HK$10,000 5 years ago, it would be worth HK$3,425 today (−65.7%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −2.9%, while this stock moved −65.7%.
Yearly Closes
Year
Year-End Close
Yearly %
2026 (YTD)
HK$15.67
−26.6%
2025
HK$21.34
―
Price1-year MA2-year MAHang Seng Index
All-Time HighHK$90.90Feb 2021
All-Time LowHK$9.24Apr 2024
Total Change−34.2%vs Dec 2018
Annualized Return−5.2%
If you had invested HK$10,000 in Dec 2018, it would be worth HK$6,584 today (−34.2%).Price change only; dividends and fees are not included.
Over the same period the Hang Seng Index moved −15.1%, while this stock moved −34.2%.
Yearly Closes
Year
Year-End Close
Yearly %
2026 (YTD)
HK$15.67
−29.7%
2025
HK$22.28
+101.4%
2024
HK$11.06
−43.1%
2023
HK$19.44
−59.9%
2022
HK$48.50
−16.4%
2021
HK$58.00
+3.6%
2020
HK$56.00
+119.6%
2019
HK$25.50
+9.4%
2018
HK$23.30
―
Daily, weekly and monthly closes (Yahoo! Finance, split-adjusted, dividends excluded). "All" covers the range Yahoo provides (from Dec 2018). Please check the latest prices before trading.
Posts
This board is shared with the Japanese and Chinese versions. Feel free to write in English, Chinese or Japanese.
No.17Disclosure2026/10/29 22:44
海外規制公告（その他）
OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* ANNOUNCEMENT ON CASH MANAGEMENT BY USING TEMPORARILY IDLE PROCEEDS
海外規制公告（その他）
OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* ANNOUNCEMENT ON THE CONVENING OF THE 2026 THIRD QUARTERLY RESULTS BRIEFING
事業の状況
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST PATIENT DOSING IN THE PHASE III CLINICAL TRIAL OF JS207 IN COMBINATION WITH JS007 FOR THE FIRST-LINE TREATMENT OF ADVANCED HEPATOCELLULAR CARCINOMA
海外規制公告（事業の状況）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
海外規制公告（その他）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
事業の状況
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF THE SUPPLEMENTAL NEW DRUG APPLICATION OF TORIPALIMAB INJECTION (SUBCUTANEOUS INJECTION) FOR THE FIRST-LINE TREATMENT OF HER2-EXPRESSING UROTHELIAL CARCINOMA
事業の状況
VOLUNTARY ANNOUNCEMENT - REGULAR APPROVAL FOR TORIPALIMAB FOR PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA WHO FAILED PLATINUM-CONTAINING CHEMOTHERAPY BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
海外規制公告（事業の状況）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
海外規制公告（事業の状況）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
海外規制公告（事業の状況）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
事業の状況
VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST PATIENT DOSING IN THE PHASE III CLINICAL TRIAL OF JS203 IN COMBINATION WITH CHEMOTHERAPY FOR THE TREATMENT OF DIFFUSE LARGE B-CELL LYMPHOMA
株式報酬制度
RESERVED GRANT OF A SHARE OPTIONS, FULFILMENT OF THE EXERCISE CONDITIONS FOR THE FIRST EXERCISE PERIOD AND CANCELLATION OF CERTAIN A SHARE OPTIONS OF THE FIRST GRANT OF A SHARE OPTIONS UNDER THE 2025 A SHARE OPTION INCENTIVE SCHEME
海外規制公告（その他）
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
海外規制公告（取締役会・監事会決議）
OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI JUNSHI BIOSCIENCES CO., LTD.* ANNOUNCEMENT ON THE RESOLUTIONS OF THE TWENTY-THIRD MEETING OF THE FOURTH SESSION OF THE BOARD OF DIRECTORS